Relationships between enterococcal verulence and antimicrobial resistance

Clinical Microbiology Reviews

Volumn 13, Issue 4, 2000, Pages 513-522

  Mundy, L M ^a   Sahm, D F ^a   Gilmore, M ^a  

^a Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL ENZYME; BACTERIAL TOXIN; CHLORAMPHENICOL; CYTOLYSIN; GELATINASE; MEMBRANE PROTEIN; METICILLIN; PENICILLIN DERIVATIVE; SUPEROXIDE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; INFECTION CONTROL; INFECTION PREVENTION; MORTALITY; NONHUMAN; PATHOGENESIS; REVIEW; DRUG EFFECT; HUMAN; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; VIRULENCE;

EID: 0033623182     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.4.513-522.2000     Document Type: Review

References (120)

1. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms
2. Hand-washing patterns in medical intensive-care units
3. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis
4. Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world
5. Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility
6. Handwashing practices in a tertiary-care, pediatric hospital and the effect on an educational program
7. Outbreak of pseudobacteremia due to multidrug-susceptible Enterococcus faecium
8. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection
9. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infections in man
10. Skin colonization with vancomycin-resistant Enterococci among hospitalized patients with bacteremia
11. Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands
12. Colonization with vancomycin-resistant Enterococcus faecium: Comparison of a long-term-care unit with an acute-care hospital
13. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci
14. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: An important infection control variable
15. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
16. Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution
17. Pathogenesis of gram-positive bacterial endophthalmitis
18. Nosocomial enterococci resistant to vancomycin - United States 1989-1993
19. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin
20. Vancomycin-resistant enterococci
21. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis
22. Bacterial sex pheromone-induced plasmid transfer
23. A novel means of self-protection, unrelated to toxin activation confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin
24. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons
25. Methicillin-resistant Staphylococcus aureus isolates recovered from a New York City hospital: Analysis by molecular fingerprinting techniques
26. Transmissible toxin (hemolysin) plasmid in Streptococcus faecalis and its mobilization of a noninfectious drug resistance plasmid
27. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
28. Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality
29. Enterococcus hirae implicated as a cause of diarrhea in suckling rats
30. A coat protein on phagosomes involved in the intracellular survival of mycobacteria
31. Common themes in microbial pathogenicity revisited
32. Independent predictive factors associated with enteric carriage of vancomycin resistant Enterococcus faecium in hospitalized patients tested for Clostridium difficile
33. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia
34. Essential role for cholesterol in entry of mycobacteria into macrophages
35. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to antibiotic determinants
36. They should have washed their hands
37. Who washes hands after using the bathroom?
38. Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution
39. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
40. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium
41. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
42. Infection control in the outpatient setting
43. Heterologous inducible expression of Enterococcus faecalis pCF10 aggregation substance asc 10 in Lactococcus lactis and Streptococcus gordonii contributes to cell hydrophobicity and adhesion to fibrin
44. Recommendations for preventing the spread of vancomycin resistance
45. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999
46. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium
47. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis
48. Augmented production of extracellular superoxide by blood isolates of Enterococcus faecalis
49. In vivo survival of Enterococcus faecalis is enhanced by extracellular superoxide production
50. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future
51. Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice
52. Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning
53. Evidence that the hemolysin/bacteriocin phenotype of Enterococcus faecalis subsp. zymogenes can be determined by plasmids in different incompatibility groups as well as by the chromosome
54. Virulence of enterococci
55. The growth inhibitory effect of the Enterococcus faecalis plasmod pAD1 encoded bacteriocin extends to the pathogenic oral streptococci
56. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthamitis
57. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains
58. Faecal carriage and nosocomial spread of Vancomycin-resistant Enterococcus faecium
59. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
60. A new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus
61. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides
62. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry
63. Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells
64. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus
65. Vibrio cholerae O139 Bengal isolated from India, Bangladesh, and Thailand are clonal as determined by pulsed-field gel electrophoresis
66. APIC guideline for handwashing and hand antisepsis in health care settings
67. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
68. Regulation of aggregation substance expression by bacterial and host factors
69. The hemolysin/bacteriocin produced by enterococci is a marker of pathogenicity
70. Differences in outcomes for patients with bactermia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium
71. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers
72. A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci
73. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
74. Vancomycin-resistant enterococci outside the healthcare setting: Prevalence, sources, and public health implications
75. Enterococcal endocarditis
76. Evidence for plasmid-mediated toxin production in Bacillus anthracis
77. Human fecal flora: The normal flora of 20 Japanese-Hawaiians
78. Enterococci resistant to multiple antimicrobial agents, including vancomycin
79. Antimicrobial use in long-term-care facilities
80. Carriage of group D streptococci in the human bowel
81. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
82. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome
83. A plasmid-encoded surface protein on Enterococcus faecalis augments its internalization by cultured intestinal epiethelial cells
84. Examination gloves as barriers to hand contamination in clinical practice
85. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality
86. Diphtheria
87. Bacterial contamination of the hands of hospital staff during routine patient care
88. Effect of disruption of a gene encoding an autolysin of Enterococcus faecalis OG1RF
89. Enterococcus faecalis bearing aggregation substance is resistant to killing by human neutrophils despite phagocytosis and neutrophil activation
90. Vancomycin-resistant Enterococcus faecium in hospitalized children
91. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
92. Aggregation and binding substances enhance pathogenicity in a rabbit model of Enterococcus faecalis endocarditis
93. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein
94. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
95. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model
96. The E. coli gene encoding heat stable toxin is a bacterial transposon flanked by inverted repeats of IS1
97. Antibiotic-indued lysis of enterococci
98. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?
99. Antimicrobial resistance in long-term-care facilities
100. Unraveling immune privilege
101. Risk factors for mortality associated with enterococcal bloodstream infections
102. vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: Effect on inter-pretation of clonality
103. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: A review for healthcare epidemiologists
104. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
105. The prevalence of colonization with vancomycin-resistant enterococcus at a Veterans Affairs institution
106. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage
107. Vancomycin-resistant enterococci
108. Enterococcus faecalis aggregation substance promotes opsonin-independent binding to human neutrophils via a complement receptor type 3-mediated mechanism
109. Lysogenic conversion by a filamentous phage encoding cholera
110. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients
111. Instituting health care reform and preserving quality: Role of the hospital epidemilogist
112. The iron triangle of health care reform
113. Perspective: Attributable mortality - The promise of better antimicrobial therapy
114. Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis
115. Colonization pattern of vancomycin-resistant Enterococcus faecium